ScholarWorks@Korea University: Hur, Gyu Young

Detailed Information

Hur, Gyu Young (허규영)

College of Medicine (Department of Medical Science)

Research Area

Tel 3034
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

asthma:7||COPD:4||Asthma:4||Biomarker:4||elderly:3||guideline:3||exacerbation:3||tuberculosis:3||Anaphylaxis:3||anaphylaxis:3||Procalcitonin:2||drug hypersensitivity syndrome:2||chronic obstructive pulmonary disease:2||inflammation:2||Oxidative stress:2||ACO:2||IgE:2||leukotriene:2||Reactive oxygen species:2||Nonsmall cell lung cancer:2||StevensJohnson syndrome:2||allergic rhinitis:2||Urticaria:2||antihistamine, treatment:1||disease management:1||psychological distress:1||Screening test:1||Pulmonary sarcomatoid carcinoma:1||inhaled corticosteroid:1||club cell secretory protein16:1||Elderly asthma:1||medication adherence:1||mass screening:1||interleukin27:1||epidemiology:1||multicenter study:1||Wild type:1||Diagnosis:1||Factor XIII:1||histological type:1||squamous cell carcinoma:1||Hymenoptera venom:1||immunotherapy:1||asthma, occupational:1||isocyanates:1||Sensitization:1||AsthmaCOPD overlap:1||toxic epidermal necrolysis:1||Muscarinic antagonists:1||Lung Diseases:1||Therapeutics:1||cyclosporine:1||Severity:1||Trigger:1||Biomarkers:1||posttraumatic:1||depression:1||Intradermal skin test:1||urinary Lhistidine:1||smoking:1||allergen:1||Surgery:1||Chronic bronchitis:1||Vascular endothelial growth factor:1||Acute Lung Injury:1||VentilatorInduced Lung Injury:1||IL4 Receptor alpha:1||lung cancer:1||prevalence:1||ERCC1:1||Gastric cancer:1||Asian patients:1||oral provocation test:1||Creactive protein:1||Baker's asthma:1||ADRB2 polymorphism:1||rifampin:1||Drugrelated side effects and adverse reactions:1||Tiotropium:1||Predictor:1||Registry:1||Eosinophils:1||stress disorders:1||anxiety:1||Bronchiectasis:1||comorbidity:1||acute exacerbation of COPD:1||Complement C1s esterase inhibitor proteins:1||allergen immunotherapy:1||multiple sites:1||microbial sensitivity tests:1||Control:1||Bacterial:1||Prognostic factor:1||Mulberry:1||Gene marker:1||Prognosis:1||Nonsmall cell lung carcinoma:1||nitric oxide:1||reference values:1||Serum:1||Transglutaminase 2:1||clinical characteristics:1||Thymidylate synthase:1||basophil activation:1||vitamin Dbinding protein:1||Interleukin18:1||levodropropizine:1||skin:1||Republic of Korea:1||Interstitial • MDA5 protein:1||zebrafish:1||Neutrophil:1||drug:1||LRRC3C:1||Positive predictive value:1||pharmacoepidemiology:1||nonsmall cell lung carcinoma:1||epidermal growth factor receptor:1||secondline treatment:1||Older:1||Lung diseases:1||Small cell lung cancer:1||food allergy:1||severity:1||serious outcomes:1||Adult:1||Smoking:1||Genetic polymorphism:1||usual interstitial pneumonia:1||idiopathic pulmonary fibrosis:1||peripheral type:1||Secondline therapy:1||componentresolved diagnosis:1||ICS:1||Registries:1||evidence:1||epithelium:1||ORMDL3:1||Neutrophils:1||Iodinated contrast media:1||StevensJohnson Syndrome:1||Treatment outcome:1||Receptor:1||Pseudomonas aeruginosa:1||virus:1||Skeletalrelated event:1||Epidermal growth factor receptor:1||Firstline chemotherapy:1||Respiration, Artificial:1||workrelated symptom:1||Allergen immunotherapy:1||Genes:1||Polymorphism:1||cardiovascular diseases:1||haplotype:1||drug allergy:1||LAMA:1||tryptase:1||Epinephrine:1||chromosome 17q21:1||Hypersensitivity reaction:1||symptom assessment:1||house dust mite:1||Programmed death ligand 1:1||epidermal growth factor:1||tobacco smoke:1||readmission:1||Angioedema:1||Koreans:1||fungating mass:1||manifestation:1||Occupational asthma:1||Chronic obstructive pulmonary disease:1||nonsmallcell lung carcinoma:1||overlap syndrome:1||Ixabepilone:1||biological markers:1||vascular endothelial growth factorA:1||Airway remodeling:1||lung function tests:1||severe cutaneous adverse reactions:1||isoniazid:1||.:1||biological variation:1||AntiInflammatory Agents:1||NonSteroidal:1||acute exacerbation:1||interleukin (IL)6:1||prognostic factors:1||biomarker:1||metabolomics:1||Immigrants:1||Bone metastases:1||Inflammation:1||neoplasm staging:1||survey:1||Predictive marker:1||Wheat Flour:1||Triple therapy:1||Antitubercular agents:1||therapeutics:1||Sensitivity:1||Drug Hypersensitivity:1||bacterial infection:1||eosinophil:1||Cough:1||evidencebased medicine:1||Allergic rhinitis:1||sublingual immunotherapy:1||bacterium:1||Hereditary angioedema types I and II:1||Mortality:1||malignant mesothelioma:1||Cognitive function:1||Interstitial:1||Pneumonia:1||single nucleotide polymorphism:1||adult:1||Respiratory Distress Syndrome, Adult:1||IL4:1||baker's asthma:1||Biologic markers:1||Pleural effusion:1||Parapneumonic effusion:1||Chemotherapy:1||Pulmonary adenocarcinoma:1||Muscle relaxant:1||low density lipoprotein receptorrelated protein2:1||specific IgG antibody:1||histamine release:1||gene polymorphisms:1||LABA:1||drug reaction with eosinophilia and systemic symptoms:1||Drug hypersensitivity syndrome:1||Treatment response:1||Mechanism:1||Hypersensitivity:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE